Crossmark

Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures

Crossref DOI link: https://doi.org/10.1186/s40478-021-01193-8

Published Online: 2021-05-17

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bradshaw, Donald V. Jr.

Knutsen, Andrew K.

Korotcov, Alexandru

Sullivan, Genevieve M.

Radomski, Kryslaine L.

Dardzinski, Bernard J.

Zi, Xiaomei

McDaniel, Dennis P.

Armstrong, Regina C. http://orcid.org/0000-0001-7296-6750
Funding

Funding for this research was provided by:

U.S. Department of Defense
License Information

Text and Data Mining valid from 2021-05-17

Version of Record valid from 2021-05-17
More Information

Article History

Received: 9 March 2021

Accepted: 6 May 2021

First Online: 17 May 2021

Declarations

:

: The authors declare no competing financial interests. Opinions are those of the authors and do not represent the University, the Department of Defense, or the federal government.

Document is current

Any future updates will be listed below